The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-13 of 13 articles
Ten-year clinical outcomes of drug-eluting stents with different polymer coating strategies by degree of coronary calcification: a pooled analysis of the ISAR-TEST 4 and 5 randomised trials
Rheude T,
Koch T,
Joner M,
Lenz T,
Xhepa E,
Wiebe J,
Coughlan J,
Aytekin A,
Cassese S,
Laugwitz K,
Schunkert H,
Kastrati A,
Kufner S
February 20, 2023 | 10.4244/EIJ-D-22-00781
Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis
Coughlan J,
Aytekin A,
Lahu S,
Scalamogna M,
Wiebe J,
Pinieck S,
Kufner S,
Xhepa E,
Joner M,
Kuna C,
Voll F,
Laugwitz K,
Schunkert H,
Kastrati A,
Cassese S
February 8, 2023 | 10.4244/EIJ-D-22-00860
Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial
Wiebe J,
Byrne R,
Alfonso F,
Maeng M,
Bradaric C,
Kretov E,
Cuesta J,
Kuna C,
Ibrahim T,
Rivero F,
Heugl M,
Christiansen E,
Joner M,
Schunkert H,
Laugwitz K,
Kastrati A,
Cassese S
March 18, 2022 | 10.4244/EIJ-D-21-00653
Outcomes of rotational atherectomy versus modified balloon angioplasty in severely calcified coronary lesions based on target lesion location: a post hoc analysis of the PREPARE-CALC randomised trial
Rheude T,
Toelg R,
Byrne R,
Allali A,
Wiebe J,
Sulimov D,
Voll F,
Cassese S,
Richardt G,
Kastrati A,
Abdel-Wahab M
July 17, 2020 | 10.4244/EIJ-D-19-00488
Predictors of haemodynamic structural valve deterioration following transcatheter aortic valve implantation with latest-generation balloon-expandable valves
Rheude T,
Pellegrini C,
Cassese S,
Wiebe J,
Wagner S,
Trenkwalder T,
Alvarez H,
Mayr P,
Hengstenberg C,
Schunkert H,
Kastrati A,
Husser O,
Joner M
February 20, 2020 | 10.4244/EIJ-D-19-00710
Sex and long-term outcomes after implantation of the Absorb bioresorbable vascular scaffold for treatment of coronary artery disease
Baquet M,
Hoppmann P,
Grundmann D,
Schmidt W,
Kufner S,
Theiss H,
Brunner S,
Wiebe J,
Eickhoff M,
Jochheim D,
Byrne R,
Laugwitz K,
Schunkert H,
Massberg S,
Kastrati A,
Mehilli J
September 20, 2019 | 10.4244/EIJ-D-18-00603
Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)
Nef H,
Wiebe J,
Kastner J,
Mehilli J,
Munzel T,
Naber C,
Neumann T,
Richardt G,
Schmermund A,
Wöhrle J,
Zahn R,
Riemer T,
Achenbach S,
Hamm C
December 20, 2017 | 10.4244/EIJ-D-17-00330
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry
Schnorbus B,
Wiebe J,
Capodanno D,
Brugaletta S,
Geraci S,
Mehilli J,
Latib A,
Lesiak M,
Jensen C,
Mattesini A,
Munzel T,
Capranzano P,
Di Mario C,
Naber C,
Araszkiewicz A,
Colombo A,
Caramanno G,
Sabaté M,
Tamburino C,
Nef H,
Gori T
October 11, 2017 | 10.4244/EIJ-D-16-00568
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score
Ortega-Paz L,
Capodanno D,
Gori T,
Nef H,
Latib A,
Caramanno G,
Di Mario C,
Naber C,
Lesiak M,
Capranzano P,
Wiebe J,
Mehilli J,
Araszkiewicz A,
Pyxaras S,
Mattesini A,
Geraci S,
Naganuma T,
Colombo A,
Munzel T,
Sabaté M,
Tamburino C,
Brugaletta S
April 20, 2017 | 10.4244/EIJ-D-16-00974
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry
Gori T,
Wiebe J,
Capodanno D,
Latib A,
Lesiak M,
Pyxaras S,
Mehilli J,
Caramanno G,
Di Mario C,
Brugaletta S,
Weber J,
Capranzano P,
Sabaté M,
Mattesini A,
Geraci S,
Naber C,
Araszkiewicz A,
Colombo A,
Tamburino C,
Nef H,
Munzel T
August 5, 2016 | 10.4244/EIJY15M09_10
Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry
Wiebe J,
Hoppmann P,
Kufner S,
Harada Y,
Colleran R,
Michel J,
Giacoppo D,
Schneider S,
Cassese S,
Ibrahim T,
Schunkert H,
Laugwitz K,
Kastrati A,
Byrne R
June 10, 2016 | 10.4244/EIJY16M05_03
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry
Capodanno D,
Gori T,
Nef H,
Latib A,
Mehilli J,
Lesiak M,
Caramanno G,
Naber C,
Di Mario C,
Colombo A,
Capranzano P,
Wiebe J,
Araszkiewicz A,
Geraci S,
Pyxaras S,
Mattesini A,
Naganuma T,
Munzel T,
Tamburino C
February 20, 2015 | 10.4244/EIJY14M07_11
Latest news
AHEAD OF PRINT
Diagnostic accuracy of OFR
FREE ARTICLE - Fukang Hu et al
March 23, 2023
#EIJonAir - Renal denervation in the management of hypertension
March 22, 2023
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Contemporary transcatheter prostheses in small annuli
FREE ARTICLE - Pier Pasquale Leone et al
March 21, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
AHEAD OF PRINT
Posterior pericardiotomy for the prevention of atrial fibrillation
FREE ARTICLE - Ahmed AbdelAziz et al
March 16, 2023
AHEAD OF PRINT
One-year outcomes with the Mistral device
FREE ARTICLE - Kerstin Piayda et al
March 13, 2023